Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis

References

• Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003; 349: 583–596
   PubMed Web of Science ®Google Scholar
• Dubrey S W, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk R H. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998; 91: 141–157
   PubMed Web of Science ®Google Scholar
• Dubrey S W, Cha K, Skinner M, LaValley M, Falk R H. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart 1997; 78: 74–82
   PubMed Web of Science ®Google Scholar
• Lachmann H J, Goodman H J, Gilbertson J A, Gallimore J R, Sabin C A, Gillmore J D, Hawkins P N. Natural history and outcome in systemic amyloidosis. New Eng J Med 2007; 356: 2361–2371
   PubMed Web of Science ®Google Scholar
• Bergesio F, Ciciani A M, Santostefano M, Brugnano R, Manganaro M, Palladini G, Di Palma A M, Gallo M, Tosi P L, Salvadori M. Immunopathology Group of the Italian Society of Nephrology. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Nephrol Dial Transplant 2008; 23: 941–951
   PubMed Web of Science ®Google Scholar
• Dubrey S W, Cha K, Simms R W, Skinner M, Falk R H. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol 1996; 77: 313–315
   PubMed Web of Science ®Google Scholar
• Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, Yamasaki S, Ida H, Kawakami A, Origuchi T, Eguchi K. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol 2003; 21: 343–346
   PubMed Web of Science ®Google Scholar
• Kyle R A, Gertz M A. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45–59
   PubMed Web of Science ®Google Scholar
• Skinner M, Sanchorawala V, Seldin D C, Dember L M, Falk R H, Berk J L, Anderson J J, O'Hara C, Finn K T, Libbey C A, Wiesman J, Quillen K, Swan N, Wright D G. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004; 140: 85–93
   PubMed Web of Science ®Google Scholar
• Dispenzieri A, Lacy M Q, Kyle R A, Therneau T M, Larson D R, Rajkumar S V, Fonseca R, Greipp P R, Witzig T E, Lust J A, Gertz M A. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol 2001; 19: 3350–3356
   PubMed Web of Science ®Google Scholar
• Stangou A J, Hawkins P N, Heaton N D, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys M B, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998; 66: 229–233
   PubMed Web of Science ®Google Scholar
• Ruygrok P N, Gane E J, McCall J L, Chen X Z, Haydock D A, Munn S R. Combined heart and liver transplantation for familial amyloidosis. Intern Med J 2001; 31: 66–67
   Google Scholar
• Selvanayagam J B, Hawkins P N, Paul B, Myerson S G, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007; 50: 2101–2110
   PubMed Web of Science ®Google Scholar
• Gertz M A, Comenzo R, Falk R H, Fermand J P, Hazenberg B P, Hawkins P N, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol 2005; 79: 319–328
   PubMed Web of Science ®Google Scholar
• Tei C, Ling L H, Hodge D O, Bailey K R, Oh J K, Rodeheffer R J, Tajik A J, Steward J B. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357–366
   PubMedGoogle Scholar
• Quinones M A, Otto C M, Stoddard M, Waggoner A, Zoghbi W A. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 67–84
   Google Scholar
• Sahn D J, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083
   PubMed Web of Science ®Google Scholar
• Nagueh S F, Middleton K J, Kopelen H A, Zoghbi W A, Quiñones M A. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527–1533
   PubMed Web of Science ®Google Scholar
• Ommen S R, Nishimura R A, Appleton C P, Miller F A, Oh J K, Redfield M M, Tajik A J. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterisation study. Circulation 2000; 102: 1788–1794
   PubMed Web of Science ®Google Scholar
• Nagueh S F, Sun H, Kopelen H A, Middleton K J, Khoury D S. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 2001; 37: 278–285
   PubMed Web of Science ®Google Scholar
• Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth O A. Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 2000; 102: 1158–1164
   PubMed Web of Science ®Google Scholar
• D'hooge J, Heimdal A, Jamal F, Kukulski T, Bijnens B, Rademakers F, Hatle L, Suetens P, Sutherland G R. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 2000; 1: 154–170
   PubMedGoogle Scholar
• Koyama J, Ray-Sequin P A, Falk R H. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 2003; 107: 2446–2452
   PubMed Web of Science ®Google Scholar
• Bellavia D, Abraham T P, Pellikka P A, Al-Zahrani G B, Dispenzieri A, Oh J K, Bailey K R, Wood C M, Novo S, Miyazaki C, Miller F A, Jr. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr 2007; 20: 1194–1202
   PubMed Web of Science ®Google Scholar
• Lindqvist P, Olofsson B O, Backman C, Suhr O, Waldenström A. Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy. Eur J Echocardiogr 2006; 7: 22–30
   PubMed Web of Science ®Google Scholar
• Baicu C F, Zile M R, Aurigemma G P, Gaasch W H. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 2005; 111: 2306–2312
   PubMed Web of Science ®Google Scholar
• Vinereanu D, Nicolaides E, Tweddel A C, Fraser A G. “Pure” diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005; 7: 820–828
   PubMed Web of Science ®Google Scholar
• Vinereanu D, Lim P O, Frenneaux M P, Fraser A G. Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure a comparison with brain natriuretic peptide. Eur J Heart Fail 2005; 7: 512–519
   PubMed Web of Science ®Google Scholar
• Maceira A M, Joshi J, Prasad S K, Moon J C, Perugini E, Harding I, Sheppard M N, Poole-Wilson P A, Hawkins P N, Pennell D J. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005; 11: 186–193
   Google Scholar
• Vogelsberg H, Mahrholdt H, Deluigi C C, Yilmaz A, Kispert E M, Greulich S, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008; 51: 1022–1030
   PubMed Web of Science ®Google Scholar
• Thomson L E. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: diagnostic value of a typical pattern of late gadolinium enhancement. J Am Coll Cardiol 2008; 51: 1031–1032
   Google Scholar
• De Keulenaer G W, Brutsaert D L. Systolic and diastolic heart failure: different phenotypes of the same disease?. Eur J Heart Fail 2007; 9: 136–143
   Google Scholar
• Suhr O B, Anan I, Backman C, Karlsson A, Lindqvist P, Mörner S, Waldenström A. Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?. J Intern Med 2008; 263: 294–301
   PubMed Web of Science ®Google Scholar
• Nordlinger M, Magnani B, Skinner M, Falk R H. Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure?. Am J Cardiol 2005; 96: 982–984
   PubMed Web of Science ®Google Scholar
• Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Perlini S, Obici L, Ascari E, d'Eril G M, Moratti R, Merlini G. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003; 107: 2440–2445
   PubMed Web of Science ®Google Scholar